Artsavit Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
Artsavit General Information
Description
Operator of drug discovery platform intended to provide treatment for cancer. The company's platform offers a drug that activates a controlled cell-killer and operates as a defense mechanism that destroys impaired and dangerous cells in the body, enabling physicians to provide to cure their cancer patients by availing these drugs.
Contact Information
Corporate Office
- Heifa
- Tel Aviv
- Israel
Corporate Office
- Heifa
- Tel Aviv
- Israel
Artsavit Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Jun-2018 | Completed | Out of Business | |||
| 3. Accelerator/Incubator | 04-Jan-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 05-Jan-2016 | $6.3M | $6.3M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Jan-2015 | Completed | Generating Revenue |
Artsavit Signals
Artsavit FAQs
-
When was Artsavit founded?
Artsavit was founded in 2014.
-
Where is Artsavit headquartered?
Artsavit is headquartered in Tel Aviv, Israel.
-
What is the size of Artsavit?
Artsavit has 4 total employees.
-
What industry is Artsavit in?
Artsavit’s primary industry is Biotechnology.
-
Is Artsavit a private or public company?
Artsavit is a Private company.
-
What is Artsavit’s current revenue?
The current revenue for Artsavit is .
-
How much funding has Artsavit raised over time?
Artsavit has raised $6.3M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process